MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 134 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $401 | +4.7% | 1,433 | 0.0% | 0.00% | 0.0% |
| Q1 2024 | $383 | +15.4% | 1,433 | 0.0% | 0.00% | 0.0% |
| Q4 2023 | $332 | -53.7% | 1,433 | -93.9% | 0.00% | 0.0% |
| Q3 2023 | $717 | +116.6% | 23,624 | +1548.6% | 0.00% | 0.0% |
| Q2 2023 | $331 | -4.6% | 1,433 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $347 | -16.6% | 1,433 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $416 | -99.6% | 1,433 | 0.0% | 0.00% | +100.0% |
| Q3 2022 | $93,000 | -9.7% | 1,433 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $103,000 | -27.0% | 1,433 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $141,000 | +16.5% | 1,433 | 0.0% | 0.00% | – |
| Q4 2021 | $121,000 | +6.1% | 1,433 | 0.0% | 0.00% | -100.0% |
| Q3 2021 | $114,000 | -18.6% | 1,433 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $140,000 | -16.7% | 1,433 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $168,000 | +5.7% | 1,433 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $159,000 | -6.5% | 1,433 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $170,000 | +4.9% | 1,433 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $162,000 | +68.8% | 1,433 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $96,000 | +43.3% | 1,433 | +95.5% | 0.00% | – |
| Q4 2019 | $67,000 | +6.3% | 733 | 0.0% | 0.00% | – |
| Q3 2019 | $63,000 | -18.2% | 733 | 0.0% | 0.00% | – |
| Q2 2019 | $77,000 | -16.3% | 733 | 0.0% | 0.00% | -100.0% |
| Q1 2019 | $92,000 | +10.8% | 733 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $83,000 | -47.1% | 733 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $157,000 | – | 733 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| University of Wisconsin Foundation | 73,487 | $17,003,422 | 28.29% |
| Tao Capital Management LP | 130,529 | $30,202 | 27.63% |
| Paulson & Co. | 1,105,741 | $255,846,353 | 23.09% |
| AlpInvest Partners B.V. | 211,488 | $48,934,093 | 11.18% |
| Bain Capital Life Sciences Investors, LLC | 324,619 | $75,110,344 | 7.20% |
| Avoro Capital Advisors LLC | 1,888,888 | $437,050,905 | 6.04% |
| Propel Bio Management, LLC | 30,032 | $6,948,804 | 5.76% |
| Baker Brothers Advisors | 1,969,798 | $455,771,861 | 5.19% |
| Rosalind Advisors, Inc. | 25,000 | $5,784,500 | 4.76% |
| TCG Crossover Management, LLC | 179,917 | $41,629,195 | 4.62% |